Table 4.
Antimicrobial susceptibility profile of Gram-negative bacteria isolated from the nasopharynx of asymptomatic primary school children at Debre Berhan town, North Shewa Ethiopia, February 1 to April 30, 2021
| Gram negative bacterial isolates | Antimicrobials tested | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C N (%) | TE N (%) | CIP N (%) | CXT N (%) | SXT N (%) | GN N (%) | AMP N (%) | AMC N (%) | CRO N (%) | CAZ N (%) | AMK N (%) | MEM N (%) | |||
| K. pneumoniae (10) | S | 3 (30) | 1 (10) | 6 (60) | 4 (40) | 3 (30) | 6 (60) | 1 (10) | 2 (80) | 4 (40) | 5 (50) | 6 (60) | 5 (50) | |
| R | 7 (70) | 9 (90) | 4 (40) | 6 (60) | 7 (70) | 4 (40) | 9 (90) | 8 (80) | 6 (60) | 5 (50) | 4 (40) | 5 (50) | ||
| K. rhinoscleromatie (9) | S | 2 (22.2) | 1 (11.1) | 5 (55.6) | 5 (55.6) | 2 (22.2) | 4 (44.4) | 1 (11.1) | 3 (33.3) | 5 (55.6) | 5 (55.6) | 4 (44.4) | 6 (66.7) | |
| R | 7 (77.8) | 8 (89.9) | 4 (44.4) | 4 (44.4) | 7 (78.8) | 5 (55.6) | 8 (89.9) | 6 (66.7) | 4 (44.4) | 4 (44.4) | 5 (55.6) | 3 (33.3) | ||
| H. Influenzae (9) | S | 3 (33.6) | 0 (0) | 6 (66.7) | 5 (55.6 | 2 (22.2) | 5 (55.6) | 1 (11.1) | 2 (22.2) | 5 (55.6 | 3 (33.3) | 5 (55.6) | 6 (66.7) | |
| R | 6 (66.4) | 9 (100) | 3 (33.3) | 4 (44.4) | 7 (77.8) | 4 (44.4) | 8 (88.9) | 7 (77.8) | 4 (44.4) | 6 (66.7) | 4 (44.4) | 3 (33.3) | ||
| K. oxytoca (6) | S | 1 (29) | 0 (0) | 4 (80) | 3 (50) | 2 (33.3) | 3 (50) | 2 (33.3) | 1 (16.7) | 4 (66.7) | 3 (50) | 4 (66.7) | 2 (33.3) | |
| R | 5 (71) | 6 (100) | 2 (20) | 3 (50) | 4 (66.7) | 3 (50) | 4 (66.7) | 5 (83.3) | 2 (33.3) | 3 (50) | 2 (33.3) | 4 (66.7) | ||
| Total (34) | S | 9 (26.5.4) | 2 (5.9) | 21 (61.8) | 17 (50) | 9 (26.5) | 18 (52.9) | 4 (11.8) | 8 (23.5) | 18 (52.8) | 16 (47) | 19 (55.9) | 18 (52.9) | |
| R | 25 (73.5) | 32 (94.1) | 13 (38.2) | 17 (50) | 25 (73.5) | 17 (47.1) | 31 (88.2) | 26 (76.5) | 17 (47.1) | 18 (53) | 15 (44.1) | 16 (47.) | ||
NT note tested, AMP Ampicillin, GN Gentamicin, AMK Amikacin CIP Ciprofloxacin (: 5 μg), SXT trimethoprim-sulfamethoxazole, MEM meropenem, AMC Amoxicillin-clavulanic acid, CTX cefotaxime, CAZ ceftazidime, CRO ceftriaxone, TE Tetracycline (:30 μg) C Chloramphenicol, TZP piperacillin tazobactam, R resistant, S sensitive